Portal de Periódicos da CAPES

The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis

2018; Wiley; Volume: 58; Issue: 3 Linguagem: Inglês

10.1111/ijd.14347

1365-4632

Tanja Todberg, Claus Zachariae, Dorrit Krustrup, Lone Skov,

Drug-Induced Adverse Reactions

International Journal of DermatologyVolume 58, Issue 3 p. e58-e61 Correspondence The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis Tanja Todberg MD, Corresponding Author tanja.todberg@regionh.dk orcid.org/0000-0002-4713-8985 Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkSearch for more papers by this authorClaus Zachariae MD, DMSc, orcid.org/0000-0001-5506-1319 Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkSearch for more papers by this authorDorrit Krustrup MD, PhD, Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, DenmarkSearch for more papers by this authorLone Skov DMSc, orcid.org/0000-0002-4784-9680 Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkSearch for more papers by this author Tanja Todberg MD, Corresponding Author tanja.todberg@regionh.dk orcid.org/0000-0002-4713-8985 Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkSearch for more papers by this authorClaus Zachariae MD, DMSc, orcid.org/0000-0001-5506-1319 Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkSearch for more papers by this authorDorrit Krustrup MD, PhD, Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, DenmarkSearch for more papers by this authorLone Skov DMSc, orcid.org/0000-0002-4784-9680 Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, DenmarkSearch for more papers by this author First published: 13 December 2018 https://doi.org/10.1111/ijd.14347Citations: 3 Funding statement: There was no external funding. This research was performed independently through the authors' academic university and hospital affiliations. Conflicts of interests: Dr. Todberg has served as an investigator for Novartis and LEO Pharma. Dr. Zachariae has consulting relationships and/or is an investigator and/or received grants or honoraria from Eli Lilly and Company, Janssen Cilag, Novartis Pharmaceutical Corp., AbbVie, Takeda, Amgen, MSD, LEO Pharmaceuticals, Boehringer-Ingelheim, Almirall, and Regeneron. Dr. Krustrup has no disclosures. Dr. Skov has been a paid speaker for Pfizer, AbbVie, Eli Lilly, Novartis, and LEO Pharma, and has been a consultant or has served on Advisory Boards with Pfizer, AbbVie, Janssen Cilag, Novartis, Eli Lilly, LEO Pharma, Almirall, and Sanofi. She has served as an investigator for Pfizer, AbbVie, Eli Lilly, Novartis, Amgen, Regeneron, Boehringer-Ingelheim, and LEO Pharma and has received research and educational grants from Pfizer, AbbVie, Novartis, Sanofi, Janssen Cilag, and LEO Pharma. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Citing Literature Volume58, Issue3March 2019Pages e58-e61 RelatedInformation